Dr. Bhavana Konda
Claim this profileOhio State University Comprehensive Cancer Center
Studies Neuroendocrine Tumors
Studies Skin Cancer
8 reported clinical trials
13 drugs studied
Area of expertise
1Neuroendocrine Tumors
Stage IV
Stage III
2Skin Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Bhavana Konda is currently running
Triapine + Targeted Radiation
for Neuroendocrine Cancer
This phase II trial compares the effect of adding triapine to lutetium Lu 177 dotatate versus lutetium Lu 177 dotatate alone (standard therapy) in shrinking tumors or slowing tumor growth in patients with neuroendocrine tumors that have spread from where they first started (primary site) to other places in the body (metastatic). Triapine may stop the growth of tumor cells by blocking some of the enzymes needed for deoxyribonucleic acid synthesis and cell growth. Lutetium Lu 177 dotatate is a radioactive drug. It binds to a protein called somatostatin receptor, which is found on some neuroendocrine tumor cells. Lutetium Lu 177 dotatate builds up in these cells and gives off radiation that may kill them. It is a type of radioconjugate and a type of somatostatin analog. Giving triapine in combination with lutetium Lu 177 dotatate may be more effective at shrinking tumors or slowing tumor growth in patients with metastatic neuroendocrine tumors than the standard therapy of lutetium Lu 177 dotatate alone.
Recruiting1 award Phase 2
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
More about Bhavana Konda
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Bhavana Konda has experience with
- Lutetium Lu 177 Dotatate
- Cabozantinib S-malate
- Ipilimumab
- Nivolumab
- Cabozantinib
- Triapine
Breakdown of trials Bhavana Konda has run
Neuroendocrine Tumors
Skin Cancer
Neuroendocrine Carcinoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bhavana Konda specialize in?
Bhavana Konda focuses on Neuroendocrine Tumors and Skin Cancer. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Bhavana Konda currently recruiting for clinical trials?
Yes, Bhavana Konda is currently recruiting for 3 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Bhavana Konda has studied deeply?
Yes, Bhavana Konda has studied treatments such as Lutetium Lu 177 Dotatate, Cabozantinib S-malate, Ipilimumab.
What is the best way to schedule an appointment with Bhavana Konda?
Apply for one of the trials that Bhavana Konda is conducting.
What is the office address of Bhavana Konda?
The office of Bhavana Konda is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.